GB201817903D0 - Anticancer treatment - Google Patents

Anticancer treatment

Info

Publication number
GB201817903D0
GB201817903D0 GBGB1817903.6A GB201817903A GB201817903D0 GB 201817903 D0 GB201817903 D0 GB 201817903D0 GB 201817903 A GB201817903 A GB 201817903A GB 201817903 D0 GB201817903 D0 GB 201817903D0
Authority
GB
United Kingdom
Prior art keywords
anticancer treatment
anticancer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1817903.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RISING TIDE FOUNDATION
Original Assignee
Novintum Biotechnology GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novintum Biotechnology GmbH filed Critical Novintum Biotechnology GmbH
Priority to GBGB1817903.6A priority Critical patent/GB201817903D0/en
Publication of GB201817903D0 publication Critical patent/GB201817903D0/en
Ceased legal-status Critical Current

Links

GBGB1817903.6A 2018-11-01 2018-11-01 Anticancer treatment Ceased GB201817903D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1817903.6A GB201817903D0 (en) 2018-11-01 2018-11-01 Anticancer treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1817903.6A GB201817903D0 (en) 2018-11-01 2018-11-01 Anticancer treatment

Publications (1)

Publication Number Publication Date
GB201817903D0 true GB201817903D0 (en) 2018-12-19

Family

ID=64655613

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1817903.6A Ceased GB201817903D0 (en) 2018-11-01 2018-11-01 Anticancer treatment

Country Status (1)

Country Link
GB (1) GB201817903D0 (en)

Similar Documents

Publication Publication Date Title
PT3576740T (en) Cancer treatment
GB201813876D0 (en) Treatment
IL268463A (en) Cancer treatment
GB201706451D0 (en) Cancer treatment
GB201800546D0 (en) Treatment
IL274626A (en) Cancer treatment
GB201707864D0 (en) Platinum-reistant cancer treatment
GB201819920D0 (en) Cancer treatment
GB201817903D0 (en) Anticancer treatment
GB201814905D0 (en) Treatment
GB201811431D0 (en) Cancer treatment
GB201718985D0 (en) Treatment
GB201711677D0 (en) Combination treatment
GB201804816D0 (en) Cancer treatment
GB201713650D0 (en) Treatment
GB201713852D0 (en) Cancer treatment
GB201803494D0 (en) Treatment regime
GB201704949D0 (en) Combination treatment
GB201706955D0 (en) Treatment
GB201706227D0 (en) Combination therapy
GB201706222D0 (en) Combination therapy
GB201706230D0 (en) Combination therapy
GB201706223D0 (en) Combination therapy
GB201706231D0 (en) Combination therapy
GB201706221D0 (en) Combination therapy

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: RISING TIDE FOUNDATION

Free format text: FORMER OWNER: NOVINTUM BIOTECHNOLOGY GMBH

AT Applications terminated before publication under section 16(1)